Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46) von Panizza, Benedict J., de Souza, Paul, Cooper, Adam, Roohullah, Aflah, Karapetis, Christos S., Lickliter, Jason D.

Volltext

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin von Po, Joseph W, Roohullah, Aflah, Lynch, David, DeFazio, Anna, Harrison, Michelle, Harnett, Paul R, Kennedy, Catherine, de Souza, Paul, Becker, Therese M

Volltext

Human Group IIA Phospholipase A2—Three Decades on from Its Discovery von Scott, Kieran F., Mann, Timothy J., Fatima, Shadma, Sajinovic, Mila, Razdan, Anshuli, Kim, Ryung Rae, Cooper, Adam, Roohullah, Aflah, Bryant, Katherine J., Gamage, Kasuni K., Harman, David G., Vafaee, Fatemeh, Graham, Garry G., Church, W. Bret, Russell, Pamela J., Dong, Qihan, de Souza, Paul

Volltext

Management of asymptomatic primary tumours in stage Ⅳ colorectal cancer: Review of outcomes von Wilkinson, Kate Jessica, Chua, Wei, Ng, Weng, Roohullah, Aflah

Volltext

Synchronous gastric and colon metastasis as an initial presentation of breast cancer: A case report von Hamad, Enas, Connor, Susan, Roohullah, Aflah, Rutland, Tristan

Volltext

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial von Llovet, Josep M, Kudo, Masatoshi, Meyer, Tim, Qin, Shukui, Ikeda, Masafumi, Ren, Zhenggang, Lim, Ho Yeong, Cheng, Ann-Lii, Galle, Peter R, Wang, Anran, Mody, Kalgi, Dutcus, Corina, Siegel, Abby B, Thompson, Alexander, Andelkovic, Vladimir, Knox, Jennifer, Davies, Janine, Asselah, Jamil, Brahmania, Mayur, Xu, Ruocai, Pan, Hongming, Gu, Kangsheng, Hao, Chunyi, Cao, Peiguo, Xiao, Juxiang, Bai, Yuxian, Chen, Xiaoming, Yan, Dong, Zhao, Hong, Bonilla, Carlos, Zambrano, Angela, Lema, Mauricio, Restrepo Gutierrez, Juan Carlos, Ramos, Victor, LeSourd, Samuel, Edeline, Julien, Bourliere, Marc, Regnault, Helene, Dauvois, Barbara, Schulze, Kornelius, Waidmann, Oliver, Berres, Marie-Luise, Berg, Thomas, Waldschmidt, Dirk T, Bitzer, Michael, Duffy, Austin, Tonini, Giuseppe, Rizzo, Mimma, Biscaldi, Elisa, Ikeda, Masafumi, Kudo, Masatoshi, Numata, Kazushi, Marusawa, Hiroyuki, Kato, Naoya, Morimoto, Manabu, Yamashita, Tatsuya, Koga, Hironori, Masaki, Tsutomu, Tateishi, Ryosuke, Inaba, Yoshitaka, Arakawa, Tomohiro, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Tae-You, Hernandez Hernandez, Carlos, Motola Kuba, Daniel, Segura Gonzalez, Manuel, Cabrera Luviano, Jesus, Ramirez Godinez, Francisco, Stedman, Catherine, Wyrwicz, Lucjan, Kraj, Leszek, Surma-Wlodarczyk, Renata, Breder, Valeriy, Sekacheva, Marina, Orlova, Rashida, Vasilyev, Alexander, Zukov, Ruslan, Minguez, Beatriz, Matilla Pena, Ana, Fernandez Castroagudin, Javier, Garcia Sanchez, Araceli, Jeng, Long-Bin, Dechaphunkul, Arunee, Seker, Mesut, Bilici, Mehmet, Cil, Timucin, Ulahannan, Susanna, Zakari, Ahmed, Feun, Lynn, Al-Rajabi, Raed, Sung, Max, Kardosh, Adel, Dodlapati, Jyothi, Agrawal, Saurabh, Gopaluni, Srivalli, Loaiza-Bonilla, Arturo, Frenette, Catherine

Volltext

First-in-human phase 1 dose escalation study of HX009, a novel recombinant humanized anti-PD-1 and CD47 bispecific antibody, in patients with advanced malignancies von Roohullah, Aflah, Ganju, Vinod, Zhang, Faming, Zhang, Lei, Yu, Ting, Wilkinson, Kate, Cooper, Adam, de Souza, Paul

Volltext

ABN401 in patients with NSCLC with MET exon 14 ( MET ex14) skipping: Result from the pilot expansion study von Lee, Dae Ho, Han, Ji-Youn, Lemech, Charlotte Rose, Millward, Michael, Roohullah, Aflah, Choi, Jun Young, Park, Kyung Eui, Kim, Na Young, Im, Sunyhe, Rajasekaran, Nirmal, Lee, Sangsuk, Moon, Hanlim, Hwang, Sunjin, Shin, YOUNGKEE, Lee, Se-Hoon

Volltext

Abstract PS10-18: Phase Ib trial of olinvacimab and pembrolizumab in patients with metastatic triple-negative breast cancer von Chan, Arlene, Moylan, Eugene, Jackson, Sally, Devoto, Jeannette, Jones, Nicola, Radmil, Silvie, Wilkinson, Kate, Roohullah, Aflah, Adam, Tamiem, Lee, Seon Young, Lee, Weon Sup, Yoo, Jin-San

Volltext

A phase 1 dose-escalation study of the ABN401 (c-MET inhibitor) in patients with solid tumors von Lee, Dae Ho, Roohullah, Aflah, Cho, Byoung Chul, Lemech, Charlotte Rose, de Souza, Paul L., Millward, Michael, Choi, Jun Young, Park, Kyung Eui, Kim, Na Young, Kim, EuiYoung, Lee, Saehyung, Kim, YeongMun, Shin, YOUNGKEE, Han, Ji-Youn

Volltext

Survival outcomes in older adults undergoing early phase clinical trials von Nindra, Udit, Childs, Sarah, Yoon, Robert, Haider, Sana, Hong, Martin, Roohullah, Aflah, Cooper, Adam, Wilkinson, Kate, Pal, Abhijit, Chua, Wei

Volltext

Options beyond BRAF targeted therapy in second-line treatment of patients with BRAFV600E mutant (BRAFmt) metastatic colorectal cancer (mCRC) von Wong, Vanessa, Hong, Wei, Ananda, Sumitra, Dunn, Catherine, Wong, Rachel, To, Yat Hang, Burge, Matthew E., Nott, Louise M., Tie, Jeanne, Shapiro, Jeremy David, Jennens, Ross, Khattak, Muhammad Adnan, Roohullah, Aflah, Gibbs, Peter

Volltext

Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity... von Lee, Dae Ho, Roohullah, Aflah, Cho, Byoung Chul, Lemech, Charlotte Rose, de Souza, Paul L., Millward, Michael, Choi, Jun Young, Park, Kyung Eui, Lee, Minseon, Kim, YeongMun, Shin, YOUNGKEE, Han, Ji-Youn

Volltext

Patients' perception of the benefits of palliative systemic therapy for advanced cancer von Subramaniam, Shalini, Adams, Diana H, Tognela, Annette, Roncolato, Felicia, Yip, Po Y, Lim, Stephanie H-S, Roohullah, Aflah, Stockler, Martin R, Kiely, Belinda

Volltext

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers von Roohullah, Aflah, Cooper, Adam, Lomax, Anna J., Aung, Jennifer, Barge, Alan, Chow, Lilian, McHale, Mark, Desai, Jayesh, Whittle, James R., Tran, Ben, de Souza, Paul, Horvath, Lisa G.

Volltext

Time toxicity associated with early phase clinical trial participation von Nindra, Udit, Shivasabesan, Gowri, Childs, Sarah, Yoon, Robert, Haider, Sana, Hong, Martin, Cooper, Adam, Roohullah, Aflah, Wilkinson, Kate, Pal, Abhijit, Chua, Wei

Volltext

Abstract 6180: First-in-human (FIH) phase I studies of SCB-313, a novel TNF-related apoptosis-inducing ligand TRAIL-Trimer™ fusion protein, for treatment of patients (pts) with mal... von Guo, Ye, Roohullah, Aflah, Xue, Junli, Zhao, Wei, Aghmesheh, Morteza, Martin, David, Zhou, Yu, Gao, Chao, Yang, Yixuan, Xu, Derek-Zhen, Li, Jin

Volltext

A phase 1 study of CRLX301, a novel nanoparticle-drug conjugate (NDC) containing docetaxel (DOC), in patients with refractory solid tumors von Markman, Ben, De Souza, Paul L., Dees, Elizabeth Claire, Gangadhar, Tara C., Cooper, Adam, Roohullah, Aflah, Boolell, Vishal, Zamboni, William, Murphy, Curran, Senderowicz, Adrian Mario, Wang, HongWei

Volltext

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities von Lim, Stephanie Hui-Su, Ip, Emilia, Ng, Weng, Chua, Wei, Asghari, Ray, Roohullah, Aflah, Descallar, Joseph, Henderson, Christopher, Spring, Kevin, de Souza, Paul, King, Madeleine T

Volltext

Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population von Min, Sandy Tun, Roohullah, Aflah, Tognela, Annette, Jalali, Azim, Lee, Margaret, Wong, Rachel, Shapiro, Jeremy, Burge, Matthew, Yip, Desmond, Nott, Louise, Zimet, Allan, Lee, Belinda, Dean, Andrew, Steel, Simone, Wong, Hui‐Li, Gibbs, Peter, Lim, Stephanie Hui‐Su

Volltext